Sangamo Therapeutics
SGMO
#10618
Rank
โ‚ฌ27.35 M
Marketcap
0,06604ย โ‚ฌ
Share price
0.00%
Change (1 day)
-88.54%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: โ‚ฌ27.35 Million

As of October 2026 Sangamo Therapeutics has a market cap of โ‚ฌ27.35 Million. This makes Sangamo Therapeutics the world's 10618th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ27.35 M-77.53%
2025โ‚ฌ0.12 B-76.28%
2024โ‚ฌ0.51 B488.9%
2023โ‚ฌ87.16 M-81.83%
2022โ‚ฌ0.47 B-50.27%
2021โ‚ฌ0.96 B-46.24%
2020โ‚ฌ1.79 B107.09%
2019โ‚ฌ0.86 B-15.5%
2018โ‚ฌ1.02 B-11.24%
2017โ‚ฌ1.15 B464.13%
2016โ‚ฌ0.20 B-65.14%
2015โ‚ฌ0.58 B-31.98%
2014โ‚ฌ0.86 B37.96%
2013โ‚ฌ0.62 B159.69%
2012โ‚ฌ0.24 B110.08%
2011โ‚ฌ0.11 B-49.34%
2010โ‚ฌ0.22 B21.84%
2009โ‚ฌ0.18 B82.26%
2008โ‚ฌ0.10 B-71.63%
2007โ‚ฌ0.35 B105.1%
2006โ‚ฌ0.17 B68.55%
2005โ‚ฌ0.10 B-6.96%
2004โ‚ฌ0.11 B3.1%
2003โ‚ฌ0.10 B52.19%
2002โ‚ฌ71.23 M-72.49%
2001โ‚ฌ0.25 B-43.52%
2000โ‚ฌ0.45 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ562.25 B 2,055,013.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ200.15 B 731,508.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ29.76 B 108,681.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚ฌ18.32 B 66,862.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ167.27 B 611,315.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ320.56 B 1,171,625.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ27.78 B 101,456.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ9.46 B 34,498.12%๐Ÿ‡บ๐Ÿ‡ธ USA